{"version":"1.0","type":"link","title":"Impact of Comorbidities on Clinical Outcomes and Quality of Life of Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Advanced Breast Cancer Treated With Palbociclib in the POLARIS Study.","author_name":"Tripathy D 외","author_url":"https://prs-insight.online/author/Tripathy%20D","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/77824","thumbnail_width":1200,"thumbnail_height":630}